67
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Quantitative Analysis and Pathological Basis of Signal Intensity on T2-Weighted MR Images in Benign and Malignant Parotid Tumors

, , , , , & show all
Pages 5423-5431 | Published online: 07 Jul 2021

References

  • Elmokadem AH, Abdel Khalek AM, Abdel Wahab RM, et al. Diagnostic accuracy of multiparametric magnetic resonance imaging for differentiation between parotid neoplasms. Can Assoc Radiol J. 2019;70(3):264–272. doi:10.1016/j.carj.2018.10.01030922790
  • Matsusue E, Fujihara Y, Matsuda E, et al. Differentiating parotid tumors by quantitative signal intensity evaluation on MR imaging. Clin Imaging. 2017;46:37–43. doi:10.1016/j.clinimag.2017.06.00928704680
  • Rooker SA, Van Abel KM, Yin LX, et al. Risk factors for subsequent recurrence after surgical treatment of recurrent pleomorphic adenoma of the parotid gland. Head Neck. 2021;43(4):1088–1096. doi:10.1002/hed.2657033275822
  • Antony J, Gopalan V, Smith RA, Lam AK. Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data. Head Neck Pathol. 2012;6(1):1–9. doi:10.1007/s12105-011-0281-z21744105
  • Liu YJ, Lee YH, Chang HC, et al. Imaging quality of PROPELLER diffusion-weighted MR imaging and its diagnostic performance in distinguishing pleomorphic adenomas from Warthin tumors of the parotid gland. NMR Biomed. 2020;33(5):e4282. doi:10.1002/nbm.428232124504
  • Yabuuchi H, Matsuo Y, Kamitani T, et al. Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization? Radiology. 2008;249(3):909–916. doi:10.1148/radiol.249307204518941162
  • Wang CW, Chu YH, Chiu DY, et al. JOURNAL CLUB: the warthin tumor score: a simple and reliable method to distinguish warthin tumors from pleomorphic adenomas and carcinomas. AJR Am J Roentgenol. 2018;210(6):1330–1337. doi:10.2214/AJR.17.1849229667889
  • Takumi K, Nagano H, Kikuno H, Kumagae Y, Fukukura Y, Yoshiura T. Differentiating malignant from benign salivary gland lesions: a multiparametric non-contrast MR imaging approach. Sci Rep. 2021;11(1):2780. doi:10.1038/s41598-021-82455-233531644
  • Tartaglione T, Botto A, Sciandra M, Gaudino S, Colosimo C. Differential diagnosis of parotid gland tumours: which magnetic resonance findings should be taken in account? Acta Otorhinolaryngol Ital. 2015;35(5):314–320. doi:10.14639/0392-100X-69326824912
  • Zhang D, Li X, Lv L, et al. A preliminary study of CT texture analysis for characterizing epithelial tumors of the parotid gland. Cancer Manag Res. 2020;12:2665–2674. doi:10.2147/CMAR.S24534432368145
  • Zhang YF, Li H, Wang XM, Cai YF. Sonoelastography for differential diagnosis between malignant and benign parotid lesions: a meta-analysis. Eur Radiol. 2019;29(2):725–735. doi:10.1007/s00330-018-5609-629992386
  • Correia-Sá I, Correia-Sá M, Costa-Ferreira P, Silva Á, Marques M. Fine-needle aspiration cytology (FNAC): is it useful in preoperative diagnosis of parotid gland lesions? Acta Chir Belg. 2017;117(2):110–114. doi:10.1080/00015458.2016.126249128002989
  • Maraghelli D, Pietragalla M, Cordopatri C, et al. Magnetic resonance imaging of salivary gland tumours: key findings for imaging characterisation. Eur J Radiol. 2021;139:109716. doi:10.1016/j.ejrad.2021.10971633866123
  • Mikaszewski B, Markiet K, Smugała A, Stodulski D, Szurowska E, Stankiewicz C. Diffusion- and perfusion-weighted magnetic resonance imaging-an alternative to fine needle biopsy or only an adjunct test in preoperative differential diagnostics of malignant and benign parotid tumors? J Oral Maxillofac Surg. 2017;75(10):2248–2253. doi:10.1016/j.joms.2017.03.01828412261
  • Espinoza S, Felter A, Malinvaud D, et al. Warthin’s tumor of parotid gland: surgery or follow-up? Diagnostic value of a decisional algorithm with functional MRI. Diagn Interv Imaging. 2016;97(1):37–43. doi:10.1016/j.diii.2014.11.02425543869
  • Zheng YM, Li J, Liu S, et al. MRI-based radiomics nomogram for differentiation of benign and malignant lesions of the parotid gland. Eur Radiol. 2020.
  • Kato H, Kanematsu M, Watanabe H, et al. Perfusion imaging of parotid gland tumours: usefulness of arterial spin labeling for differentiating Warthin’s tumours. Eur Radiol. 2015;25(11):3247–3254. doi:10.1007/s00330-015-3755-725921591
  • Mikaszewski B, Markiet K, Smugała A, Stodulski D, Szurowska E, Stankiewicz C. Clinical and demographic data improve diagnostic accuracy of dynamic contrast-enhanced and diffusion-weighted MRI in differential diagnostics of parotid gland tumors. Oral Oncol. 2020;111:104932. doi:10.1016/j.oraloncology.2020.10493232739792
  • Yabuuchi H, Kamitani T, Sagiyama K, et al. Characterization of parotid gland tumors: added value of permeability MR imaging to DWI and DCE-MRI. Eur Radiol. 2020;30(12):6402–6412. doi:10.1007/s00330-020-07004-332613285
  • Jiang JS, Zhu LN, Chen W, et al. Added value of susceptibility- weighted imaging to diffusion-weighted imaging in the characterization of parotid gland tumors. Eur Arch Otorhinolaryngol. 2020;277(10):2839–2846. doi:10.1007/s00405-020-05985-x32328768
  • Ikeda M, Motoori K, Hanazawa T, et al. Warthin tumor of the parotid gland: diagnostic value of MR imaging with histopathologic correlation. AJNR Am J Neuroradiol. 2004;25(7):1256–1262.15313720
  • Kato H, Fujimoto K, Matsuo M, Mizuta K, Aoki M. Usefulness of diffusion-weighted MR imaging for differentiating between Warthin’s tumor and oncocytoma of the parotid gland. Jpn J Radiol. 2017;35(2):78–85. doi:10.1007/s11604-016-0608-528074380
  • Motoori K, Yamamoto S, Ueda T, et al. Inter- and intratumoral variability in magnetic resonance imaging of pleomorphic adenoma: an attempt to interpret the variable magnetic resonance findings. J Comput Assist Tomogr. 2004;28(2):233–246. doi:10.1097/00004728-200403000-0001415091129
  • Wei PY, Shao C, Huan T, Wang HB, Ding ZX, Han ZJ. Diagnostic value of maximum signal intensity on T1-weighted MRI images for differentiating parotid gland tumours along with pathological correlation. Clin Radiol. 2021;76(6):472.e19–472.e25. doi:10.1016/j.crad.2021.02.011
  • Minami M, Tanioka H, Oyama K, Itai Y, Sasaki Y. Warthin tumor of the parotid gland: MR-pathologic correlation. AJNR. 1993;14(1):209–214.8427092
  • Choi SY, Lee E, Kim E, et al. Clinical outcomes of bulky parotid gland cancers: need for self-examination and screening program for early diagnosis of parotid tumors. BMC Cancer. 2021;21(1):178. doi:10.1186/s12885-021-07902-933602169
  • Xu Z, Zheng S, Pan A, Cheng X, Gao M. A multiparametric analysis based on DCE-MRI to improve the accuracy of parotid tumor discrimination. Eur J Nucl Med Mol Imaging. 2019;46(11):2228–2234. doi:10.1007/s00259-019-04447-931372671
  • Xu Y, Shu Z, Song G, et al. The role of preoperative computed tomography radiomics in distinguishing benign and malignant tumors of the parotid gland. Front Oncol. 2021;11:634452. doi:10.3389/fonc.2021.63445233777789